|1||Introduction: The Pharmaceutical Industry and the Drug Development Process |
Instructors: Stan N. Finkelstein, M.D., Robert H. Rubin, M.D., Anthony J. Sinskey, Ph.D.
|2||Basic Science Part I – Discovery Innovation and Emerging Technologies, Basic Business |
Instructors: Anthony J. Sinskey, Ph.D.
Guest Lecturer: Robert Mulroy, President and CEO, Merrimack Pharmaceuticals
|3||Examples of Druggability Issues in the Pharmaceutical Industry |
Guest Lecturer: Frank Douglas, Ph.D.
FDA Drug Regulatory Process
Instructor: Stan N. Finkelstein, M.D.
|4||Basic Science Part II – Molecular Toxicology in Preclinical Studies |
Instructor: Anthony J. Sinskey, Ph.D.
|5||Pharmaceutical Manufacturing Part I |
Instructors: Charles L. Cooney, Ph.D.
|6||Pharmaceutical Manufacturing Part II |
Guest Lecturer: G. K. Raju, Ph.D.
Clustering Effects in Biotech Companies, Organization and Management
|8||Valuing Pharmaceutical and Biotech Companies |
Guest Lecturer: Terrence W. Norchi, M.D., MBA, Former Senior Equity Analyst and Portfolio Manager, Putnam Securities
Policy and Economic Considerations in Drug Development
Instructor: Stan Finkelstein, M.D.
|9||Putting it all Together: A System Dynamics Model of the Anti-cholesterol Drugs Market |
Instructor: Charles L. Cooney, Ph.D.
Guest Lecturer: Henry B. Weil, M.S.
Analyzing the Human Genome Project
Instructor: Fiona Murray, Ph.D.
|10||Development and Impact of Genetic Tests |
Instructor: Jessica Lang-Kosa, Ph.D., MIT Postdoctoral Fellow, POPI
Supply Chain Management in the Pharmaceutical Industry
Guest Lecturer: David Simchi-Levi, Ph.D.
|11||The Impact of Pedigree on Drug Supply Chains |
Guest Lecturer: Daniel W. Engels, Ph.D., Director, HRI
The Biotech Disruption to Anti-Cancer Drug Development
Guest Lecturer: Lourdes Sosa, Ph.D. Candidate, Sloan School, TIE Program
|12||Global Health and the Pharmaceutical Industry in 3rd World Countries |
Instructor: Robert H. Rubin, M.D.
Guest Lecturers: John Swen, Alexander Fleming